COVID-19 Impact on Global Prescription Arthritis Medications Market Insights, Forecast to 2026
Arthritis medicines are generally very effective in helping people with arthritis to manage joint pain and other symptoms.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Prescription Arthritis Medications market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Prescription Arthritis Medications industry.
Based on our recent survey, we have several different scenarios about the Prescription Arthritis Medications YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Prescription Arthritis Medications will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prescription Arthritis Medications market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prescription Arthritis Medications market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Prescription Arthritis Medications market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Prescription Arthritis Medications market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Prescription Arthritis Medications market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Prescription Arthritis Medications market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prescription Arthritis Medications market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prescription Arthritis Medications market.
The following manufacturers are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Prescription Arthritis Medications market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Prescription Arthritis Medications industry.
Based on our recent survey, we have several different scenarios about the Prescription Arthritis Medications YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Prescription Arthritis Medications will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prescription Arthritis Medications market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prescription Arthritis Medications market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Prescription Arthritis Medications market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Prescription Arthritis Medications market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Prescription Arthritis Medications market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Prescription Arthritis Medications market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prescription Arthritis Medications market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prescription Arthritis Medications market.
The following manufacturers are covered in this report:
- Abbott
- Amgen
- Boehringer Ingelheim
- Horizon Pharma
- Novartis
- Pfizer
- Regeneron
- Oral
- Topical
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
1 STUDY COVERAGE
1.1 Prescription Arthritis Medications Product Introduction
1.2 Market Segments
1.3 Key Prescription Arthritis Medications Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Prescription Arthritis Medications Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Topical
1.5 Market by Application
1.5.1 Global Prescription Arthritis Medications Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Prescription Arthritis Medications Industry Impact
1.6.1 How the Covid-19 is Affecting the Prescription Arthritis Medications Industry
1.6.1.1 Prescription Arthritis Medications Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Prescription Arthritis Medications Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Prescription Arthritis Medications Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Prescription Arthritis Medications Market Size Estimates and Forecasts
2.1.1 Global Prescription Arthritis Medications Revenue 2015-2026
2.1.2 Global Prescription Arthritis Medications Sales 2015-2026
2.2 Prescription Arthritis Medications Market Size by Region: 2020 Versus 2026
2.2.1 Global Prescription Arthritis Medications Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Prescription Arthritis Medications Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PRESCRIPTION ARTHRITIS MEDICATIONS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Prescription Arthritis Medications Sales by Manufacturers
3.1.1 Prescription Arthritis Medications Sales by Manufacturers (2015-2020)
3.1.2 Prescription Arthritis Medications Sales Market Share by Manufacturers (2015-2020)
3.2 Prescription Arthritis Medications Revenue by Manufacturers
3.2.1 Prescription Arthritis Medications Revenue by Manufacturers (2015-2020)
3.2.2 Prescription Arthritis Medications Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Prescription Arthritis Medications Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Prescription Arthritis Medications Revenue in 2019
3.2.5 Global Prescription Arthritis Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Prescription Arthritis Medications Price by Manufacturers
3.4 Prescription Arthritis Medications Manufacturing Base Distribution, Product Types
3.4.1 Prescription Arthritis Medications Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Prescription Arthritis Medications Product Type
3.4.3 Date of International Manufacturers Enter into Prescription Arthritis Medications Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Prescription Arthritis Medications Market Size by Type (2015-2020)
4.1.1 Global Prescription Arthritis Medications Sales by Type (2015-2020)
4.1.2 Global Prescription Arthritis Medications Revenue by Type (2015-2020)
4.1.3 Prescription Arthritis Medications Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Prescription Arthritis Medications Market Size Forecast by Type (2021-2026)
4.2.1 Global Prescription Arthritis Medications Sales Forecast by Type (2021-2026)
4.2.2 Global Prescription Arthritis Medications Revenue Forecast by Type (2021-2026)
4.2.3 Prescription Arthritis Medications Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Prescription Arthritis Medications Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Prescription Arthritis Medications Market Size by Application (2015-2020)
5.1.1 Global Prescription Arthritis Medications Sales by Application (2015-2020)
5.1.2 Global Prescription Arthritis Medications Revenue by Application (2015-2020)
5.1.3 Prescription Arthritis Medications Price by Application (2015-2020)
5.2 Prescription Arthritis Medications Market Size Forecast by Application (2021-2026)
5.2.1 Global Prescription Arthritis Medications Sales Forecast by Application (2021-2026)
5.2.2 Global Prescription Arthritis Medications Revenue Forecast by Application (2021-2026)
5.2.3 Global Prescription Arthritis Medications Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Prescription Arthritis Medications by Country
6.1.1 North America Prescription Arthritis Medications Sales by Country
6.1.2 North America Prescription Arthritis Medications Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Prescription Arthritis Medications Market Facts & Figures by Type
6.3 North America Prescription Arthritis Medications Market Facts & Figures by Application
7 EUROPE
7.1 Europe Prescription Arthritis Medications by Country
7.1.1 Europe Prescription Arthritis Medications Sales by Country
7.1.2 Europe Prescription Arthritis Medications Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Prescription Arthritis Medications Market Facts & Figures by Type
7.3 Europe Prescription Arthritis Medications Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Prescription Arthritis Medications by Region
8.1.1 Asia Pacific Prescription Arthritis Medications Sales by Region
8.1.2 Asia Pacific Prescription Arthritis Medications Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Prescription Arthritis Medications Market Facts & Figures by Type
8.3 Asia Pacific Prescription Arthritis Medications Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Prescription Arthritis Medications by Country
9.1.1 Latin America Prescription Arthritis Medications Sales by Country
9.1.2 Latin America Prescription Arthritis Medications Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Prescription Arthritis Medications Market Facts & Figures by Type
9.3 Central & South America Prescription Arthritis Medications Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Prescription Arthritis Medications by Country
10.1.1 Middle East and Africa Prescription Arthritis Medications Sales by Country
10.1.2 Middle East and Africa Prescription Arthritis Medications Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Prescription Arthritis Medications Market Facts & Figures by Type
10.3 Middle East and Africa Prescription Arthritis Medications Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Description, Business Overview and Total Revenue
11.1.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Prescription Arthritis Medications Products Offered
11.1.5 Abbott Recent Development
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Description, Business Overview and Total Revenue
11.2.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Prescription Arthritis Medications Products Offered
11.2.5 Amgen Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.3.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Boehringer Ingelheim Prescription Arthritis Medications Products Offered
11.3.5 Boehringer Ingelheim Recent Development
11.4 Horizon Pharma
11.4.1 Horizon Pharma Corporation Information
11.4.2 Horizon Pharma Description, Business Overview and Total Revenue
11.4.3 Horizon Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Horizon Pharma Prescription Arthritis Medications Products Offered
11.4.5 Horizon Pharma Recent Development
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Description, Business Overview and Total Revenue
11.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis Prescription Arthritis Medications Products Offered
11.5.5 Novartis Recent Development
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Description, Business Overview and Total Revenue
11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer Prescription Arthritis Medications Products Offered
11.6.5 Pfizer Recent Development
11.7 Regeneron
11.7.1 Regeneron Corporation Information
11.7.2 Regeneron Description, Business Overview and Total Revenue
11.7.3 Regeneron Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Regeneron Prescription Arthritis Medications Products Offered
11.7.5 Regeneron Recent Development
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Description, Business Overview and Total Revenue
11.1.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Prescription Arthritis Medications Products Offered
11.1.5 Abbott Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Prescription Arthritis Medications Market Estimates and Projections by Region
12.1.1 Global Prescription Arthritis Medications Sales Forecast by Regions 2021-2026
12.1.2 Global Prescription Arthritis Medications Revenue Forecast by Regions 2021-2026
12.2 North America Prescription Arthritis Medications Market Size Forecast (2021-2026)
12.2.1 North America: Prescription Arthritis Medications Sales Forecast (2021-2026)
12.2.2 North America: Prescription Arthritis Medications Revenue Forecast (2021-2026)
12.2.3 North America: Prescription Arthritis Medications Market Size Forecast by Country (2021-2026)
12.3 Europe Prescription Arthritis Medications Market Size Forecast (2021-2026)
12.3.1 Europe: Prescription Arthritis Medications Sales Forecast (2021-2026)
12.3.2 Europe: Prescription Arthritis Medications Revenue Forecast (2021-2026)
12.3.3 Europe: Prescription Arthritis Medications Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Prescription Arthritis Medications Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Prescription Arthritis Medications Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Prescription Arthritis Medications Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Prescription Arthritis Medications Market Size Forecast by Region (2021-2026)
12.5 Latin America Prescription Arthritis Medications Market Size Forecast (2021-2026)
12.5.1 Latin America: Prescription Arthritis Medications Sales Forecast (2021-2026)
12.5.2 Latin America: Prescription Arthritis Medications Revenue Forecast (2021-2026)
12.5.3 Latin America: Prescription Arthritis Medications Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Prescription Arthritis Medications Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Prescription Arthritis Medications Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Prescription Arthritis Medications Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Prescription Arthritis Medications Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Prescription Arthritis Medications Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Prescription Arthritis Medications Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Prescription Arthritis Medications Product Introduction
1.2 Market Segments
1.3 Key Prescription Arthritis Medications Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Prescription Arthritis Medications Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Topical
1.5 Market by Application
1.5.1 Global Prescription Arthritis Medications Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Prescription Arthritis Medications Industry Impact
1.6.1 How the Covid-19 is Affecting the Prescription Arthritis Medications Industry
1.6.1.1 Prescription Arthritis Medications Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Prescription Arthritis Medications Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Prescription Arthritis Medications Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Prescription Arthritis Medications Market Size Estimates and Forecasts
2.1.1 Global Prescription Arthritis Medications Revenue 2015-2026
2.1.2 Global Prescription Arthritis Medications Sales 2015-2026
2.2 Prescription Arthritis Medications Market Size by Region: 2020 Versus 2026
2.2.1 Global Prescription Arthritis Medications Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Prescription Arthritis Medications Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PRESCRIPTION ARTHRITIS MEDICATIONS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Prescription Arthritis Medications Sales by Manufacturers
3.1.1 Prescription Arthritis Medications Sales by Manufacturers (2015-2020)
3.1.2 Prescription Arthritis Medications Sales Market Share by Manufacturers (2015-2020)
3.2 Prescription Arthritis Medications Revenue by Manufacturers
3.2.1 Prescription Arthritis Medications Revenue by Manufacturers (2015-2020)
3.2.2 Prescription Arthritis Medications Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Prescription Arthritis Medications Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Prescription Arthritis Medications Revenue in 2019
3.2.5 Global Prescription Arthritis Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Prescription Arthritis Medications Price by Manufacturers
3.4 Prescription Arthritis Medications Manufacturing Base Distribution, Product Types
3.4.1 Prescription Arthritis Medications Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Prescription Arthritis Medications Product Type
3.4.3 Date of International Manufacturers Enter into Prescription Arthritis Medications Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Prescription Arthritis Medications Market Size by Type (2015-2020)
4.1.1 Global Prescription Arthritis Medications Sales by Type (2015-2020)
4.1.2 Global Prescription Arthritis Medications Revenue by Type (2015-2020)
4.1.3 Prescription Arthritis Medications Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Prescription Arthritis Medications Market Size Forecast by Type (2021-2026)
4.2.1 Global Prescription Arthritis Medications Sales Forecast by Type (2021-2026)
4.2.2 Global Prescription Arthritis Medications Revenue Forecast by Type (2021-2026)
4.2.3 Prescription Arthritis Medications Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Prescription Arthritis Medications Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Prescription Arthritis Medications Market Size by Application (2015-2020)
5.1.1 Global Prescription Arthritis Medications Sales by Application (2015-2020)
5.1.2 Global Prescription Arthritis Medications Revenue by Application (2015-2020)
5.1.3 Prescription Arthritis Medications Price by Application (2015-2020)
5.2 Prescription Arthritis Medications Market Size Forecast by Application (2021-2026)
5.2.1 Global Prescription Arthritis Medications Sales Forecast by Application (2021-2026)
5.2.2 Global Prescription Arthritis Medications Revenue Forecast by Application (2021-2026)
5.2.3 Global Prescription Arthritis Medications Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Prescription Arthritis Medications by Country
6.1.1 North America Prescription Arthritis Medications Sales by Country
6.1.2 North America Prescription Arthritis Medications Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Prescription Arthritis Medications Market Facts & Figures by Type
6.3 North America Prescription Arthritis Medications Market Facts & Figures by Application
7 EUROPE
7.1 Europe Prescription Arthritis Medications by Country
7.1.1 Europe Prescription Arthritis Medications Sales by Country
7.1.2 Europe Prescription Arthritis Medications Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Prescription Arthritis Medications Market Facts & Figures by Type
7.3 Europe Prescription Arthritis Medications Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Prescription Arthritis Medications by Region
8.1.1 Asia Pacific Prescription Arthritis Medications Sales by Region
8.1.2 Asia Pacific Prescription Arthritis Medications Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Prescription Arthritis Medications Market Facts & Figures by Type
8.3 Asia Pacific Prescription Arthritis Medications Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Prescription Arthritis Medications by Country
9.1.1 Latin America Prescription Arthritis Medications Sales by Country
9.1.2 Latin America Prescription Arthritis Medications Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Prescription Arthritis Medications Market Facts & Figures by Type
9.3 Central & South America Prescription Arthritis Medications Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Prescription Arthritis Medications by Country
10.1.1 Middle East and Africa Prescription Arthritis Medications Sales by Country
10.1.2 Middle East and Africa Prescription Arthritis Medications Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Prescription Arthritis Medications Market Facts & Figures by Type
10.3 Middle East and Africa Prescription Arthritis Medications Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Description, Business Overview and Total Revenue
11.1.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Prescription Arthritis Medications Products Offered
11.1.5 Abbott Recent Development
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Description, Business Overview and Total Revenue
11.2.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Prescription Arthritis Medications Products Offered
11.2.5 Amgen Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.3.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Boehringer Ingelheim Prescription Arthritis Medications Products Offered
11.3.5 Boehringer Ingelheim Recent Development
11.4 Horizon Pharma
11.4.1 Horizon Pharma Corporation Information
11.4.2 Horizon Pharma Description, Business Overview and Total Revenue
11.4.3 Horizon Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Horizon Pharma Prescription Arthritis Medications Products Offered
11.4.5 Horizon Pharma Recent Development
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Description, Business Overview and Total Revenue
11.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis Prescription Arthritis Medications Products Offered
11.5.5 Novartis Recent Development
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Description, Business Overview and Total Revenue
11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer Prescription Arthritis Medications Products Offered
11.6.5 Pfizer Recent Development
11.7 Regeneron
11.7.1 Regeneron Corporation Information
11.7.2 Regeneron Description, Business Overview and Total Revenue
11.7.3 Regeneron Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Regeneron Prescription Arthritis Medications Products Offered
11.7.5 Regeneron Recent Development
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Description, Business Overview and Total Revenue
11.1.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Prescription Arthritis Medications Products Offered
11.1.5 Abbott Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Prescription Arthritis Medications Market Estimates and Projections by Region
12.1.1 Global Prescription Arthritis Medications Sales Forecast by Regions 2021-2026
12.1.2 Global Prescription Arthritis Medications Revenue Forecast by Regions 2021-2026
12.2 North America Prescription Arthritis Medications Market Size Forecast (2021-2026)
12.2.1 North America: Prescription Arthritis Medications Sales Forecast (2021-2026)
12.2.2 North America: Prescription Arthritis Medications Revenue Forecast (2021-2026)
12.2.3 North America: Prescription Arthritis Medications Market Size Forecast by Country (2021-2026)
12.3 Europe Prescription Arthritis Medications Market Size Forecast (2021-2026)
12.3.1 Europe: Prescription Arthritis Medications Sales Forecast (2021-2026)
12.3.2 Europe: Prescription Arthritis Medications Revenue Forecast (2021-2026)
12.3.3 Europe: Prescription Arthritis Medications Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Prescription Arthritis Medications Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Prescription Arthritis Medications Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Prescription Arthritis Medications Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Prescription Arthritis Medications Market Size Forecast by Region (2021-2026)
12.5 Latin America Prescription Arthritis Medications Market Size Forecast (2021-2026)
12.5.1 Latin America: Prescription Arthritis Medications Sales Forecast (2021-2026)
12.5.2 Latin America: Prescription Arthritis Medications Revenue Forecast (2021-2026)
12.5.3 Latin America: Prescription Arthritis Medications Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Prescription Arthritis Medications Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Prescription Arthritis Medications Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Prescription Arthritis Medications Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Prescription Arthritis Medications Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Prescription Arthritis Medications Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Prescription Arthritis Medications Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Prescription Arthritis Medications Market Segments
Table 2. Ranking of Global Top Prescription Arthritis Medications Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Prescription Arthritis Medications Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Topical
Table 6. COVID-19 Impact Global Market: (Four Prescription Arthritis Medications Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Prescription Arthritis Medications Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Prescription Arthritis Medications Players to Combat Covid-19 Impact
Table 11. Global Prescription Arthritis Medications Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Prescription Arthritis Medications Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Prescription Arthritis Medications Sales by Regions 2015-2020 (K Units)
Table 14. Global Prescription Arthritis Medications Sales Market Share by Regions (2015-2020)
Table 15. Global Prescription Arthritis Medications Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Prescription Arthritis Medications Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Prescription Arthritis Medications Sales Share by Manufacturers (2015-2020)
Table 18. Global Prescription Arthritis Medications Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Prescription Arthritis Medications by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prescription Arthritis Medications as of 2019)
Table 20. Prescription Arthritis Medications Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Prescription Arthritis Medications Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Prescription Arthritis Medications Price (2015-2020) (USD/Unit)
Table 23. Prescription Arthritis Medications Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Prescription Arthritis Medications Product Type
Table 25. Date of International Manufacturers Enter into Prescription Arthritis Medications Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Prescription Arthritis Medications Sales by Type (2015-2020) (K Units)
Table 28. Global Prescription Arthritis Medications Sales Share by Type (2015-2020)
Table 29. Global Prescription Arthritis Medications Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Prescription Arthritis Medications Revenue Share by Type (2015-2020)
Table 31. Prescription Arthritis Medications Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Prescription Arthritis Medications Sales by Application (2015-2020) (K Units)
Table 33. Global Prescription Arthritis Medications Sales Share by Application (2015-2020)
Table 34. North America Prescription Arthritis Medications Sales by Country (2015-2020) (K Units)
Table 35. North America Prescription Arthritis Medications Sales Market Share by Country (2015-2020)
Table 36. North America Prescription Arthritis Medications Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Prescription Arthritis Medications Revenue Market Share by Country (2015-2020)
Table 38. North America Prescription Arthritis Medications Sales by Type (2015-2020) (K Units)
Table 39. North America Prescription Arthritis Medications Sales Market Share by Type (2015-2020)
Table 40. North America Prescription Arthritis Medications Sales by Application (2015-2020) (K Units)
Table 41. North America Prescription Arthritis Medications Sales Market Share by Application (2015-2020)
Table 42. Europe Prescription Arthritis Medications Sales by Country (2015-2020) (K Units)
Table 43. Europe Prescription Arthritis Medications Sales Market Share by Country (2015-2020)
Table 44. Europe Prescription Arthritis Medications Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Prescription Arthritis Medications Revenue Market Share by Country (2015-2020)
Table 46. Europe Prescription Arthritis Medications Sales by Type (2015-2020) (K Units)
Table 47. Europe Prescription Arthritis Medications Sales Market Share by Type (2015-2020)
Table 48. Europe Prescription Arthritis Medications Sales by Application (2015-2020) (K Units)
Table 49. Europe Prescription Arthritis Medications Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Prescription Arthritis Medications Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Prescription Arthritis Medications Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Prescription Arthritis Medications Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Prescription Arthritis Medications Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Prescription Arthritis Medications Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Prescription Arthritis Medications Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Prescription Arthritis Medications Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Prescription Arthritis Medications Sales Market Share by Application (2015-2020)
Table 58. Latin America Prescription Arthritis Medications Sales by Country (2015-2020) (K Units)
Table 59. Latin America Prescription Arthritis Medications Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Prescription Arthritis Medications Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Prescription Arthritis Medications Revenue Market Share by Country (2015-2020)
Table 62. Latin America Prescription Arthritis Medications Sales by Type (2015-2020) (K Units)
Table 63. Latin America Prescription Arthritis Medications Sales Market Share by Type (2015-2020)
Table 64. Latin America Prescription Arthritis Medications Sales by Application (2015-2020) (K Units)
Table 65. Latin America Prescription Arthritis Medications Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Prescription Arthritis Medications Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Prescription Arthritis Medications Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Prescription Arthritis Medications Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Prescription Arthritis Medications Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Prescription Arthritis Medications Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Prescription Arthritis Medications Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Prescription Arthritis Medications Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Prescription Arthritis Medications Sales Market Share by Application (2015-2020)
Table 74. Abbott Corporation Information
Table 75. Abbott Description and Major Businesses
Table 76. Abbott Prescription Arthritis Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Abbott Product
Table 78. Abbott Recent Development
Table 79. Amgen Corporation Information
Table 80. Amgen Description and Major Businesses
Table 81. Amgen Prescription Arthritis Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Amgen Product
Table 83. Amgen Recent Development
Table 84. Boehringer Ingelheim Corporation Information
Table 85. Boehringer Ingelheim Description and Major Businesses
Table 86. Boehringer Ingelheim Prescription Arthritis Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Boehringer Ingelheim Product
Table 88. Boehringer Ingelheim Recent Development
Table 89. Horizon Pharma Corporation Information
Table 90. Horizon Pharma Description and Major Businesses
Table 91. Horizon Pharma Prescription Arthritis Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Horizon Pharma Product
Table 93. Horizon Pharma Recent Development
Table 94. Novartis Corporation Information
Table 95. Novartis Description and Major Businesses
Table 96. Novartis Prescription Arthritis Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Novartis Product
Table 98. Novartis Recent Development
Table 99. Pfizer Corporation Information
Table 100. Pfizer Description and Major Businesses
Table 101. Pfizer Prescription Arthritis Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Pfizer Product
Table 103. Pfizer Recent Development
Table 104. Regeneron Corporation Information
Table 105. Regeneron Description and Major Businesses
Table 106. Regeneron Prescription Arthritis Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Regeneron Product
Table 108. Regeneron Recent Development
Table 109. Global Prescription Arthritis Medications Sales Forecast by Regions (2021-2026) (K Units)
Table 110. Global Prescription Arthritis Medications Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Prescription Arthritis Medications Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Prescription Arthritis Medications Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Prescription Arthritis Medications Sales Forecast by Country (2021-2026) (K Units)
Table 114. North America: Prescription Arthritis Medications Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Prescription Arthritis Medications Sales Forecast by Country (2021-2026) (K Units)
Table 116. Europe: Prescription Arthritis Medications Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Prescription Arthritis Medications Sales Forecast by Region (2021-2026) (K Units)
Table 118. Asia Pacific: Prescription Arthritis Medications Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Prescription Arthritis Medications Sales Forecast by Country (2021-2026) (K Units)
Table 120. Latin America: Prescription Arthritis Medications Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Prescription Arthritis Medications Sales Forecast by Country (2021-2026) (K Units)
Table 122. Middle East and Africa: Prescription Arthritis Medications Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Prescription Arthritis Medications Players
Table 127. Prescription Arthritis Medications Customers List
Table 128. Prescription Arthritis Medications Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
Table 1. Prescription Arthritis Medications Market Segments
Table 2. Ranking of Global Top Prescription Arthritis Medications Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Prescription Arthritis Medications Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Topical
Table 6. COVID-19 Impact Global Market: (Four Prescription Arthritis Medications Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Prescription Arthritis Medications Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Prescription Arthritis Medications Players to Combat Covid-19 Impact
Table 11. Global Prescription Arthritis Medications Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Prescription Arthritis Medications Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Prescription Arthritis Medications Sales by Regions 2015-2020 (K Units)
Table 14. Global Prescription Arthritis Medications Sales Market Share by Regions (2015-2020)
Table 15. Global Prescription Arthritis Medications Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Prescription Arthritis Medications Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Prescription Arthritis Medications Sales Share by Manufacturers (2015-2020)
Table 18. Global Prescription Arthritis Medications Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Prescription Arthritis Medications by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prescription Arthritis Medications as of 2019)
Table 20. Prescription Arthritis Medications Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Prescription Arthritis Medications Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Prescription Arthritis Medications Price (2015-2020) (USD/Unit)
Table 23. Prescription Arthritis Medications Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Prescription Arthritis Medications Product Type
Table 25. Date of International Manufacturers Enter into Prescription Arthritis Medications Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Prescription Arthritis Medications Sales by Type (2015-2020) (K Units)
Table 28. Global Prescription Arthritis Medications Sales Share by Type (2015-2020)
Table 29. Global Prescription Arthritis Medications Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Prescription Arthritis Medications Revenue Share by Type (2015-2020)
Table 31. Prescription Arthritis Medications Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Prescription Arthritis Medications Sales by Application (2015-2020) (K Units)
Table 33. Global Prescription Arthritis Medications Sales Share by Application (2015-2020)
Table 34. North America Prescription Arthritis Medications Sales by Country (2015-2020) (K Units)
Table 35. North America Prescription Arthritis Medications Sales Market Share by Country (2015-2020)
Table 36. North America Prescription Arthritis Medications Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Prescription Arthritis Medications Revenue Market Share by Country (2015-2020)
Table 38. North America Prescription Arthritis Medications Sales by Type (2015-2020) (K Units)
Table 39. North America Prescription Arthritis Medications Sales Market Share by Type (2015-2020)
Table 40. North America Prescription Arthritis Medications Sales by Application (2015-2020) (K Units)
Table 41. North America Prescription Arthritis Medications Sales Market Share by Application (2015-2020)
Table 42. Europe Prescription Arthritis Medications Sales by Country (2015-2020) (K Units)
Table 43. Europe Prescription Arthritis Medications Sales Market Share by Country (2015-2020)
Table 44. Europe Prescription Arthritis Medications Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Prescription Arthritis Medications Revenue Market Share by Country (2015-2020)
Table 46. Europe Prescription Arthritis Medications Sales by Type (2015-2020) (K Units)
Table 47. Europe Prescription Arthritis Medications Sales Market Share by Type (2015-2020)
Table 48. Europe Prescription Arthritis Medications Sales by Application (2015-2020) (K Units)
Table 49. Europe Prescription Arthritis Medications Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Prescription Arthritis Medications Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Prescription Arthritis Medications Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Prescription Arthritis Medications Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Prescription Arthritis Medications Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Prescription Arthritis Medications Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Prescription Arthritis Medications Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Prescription Arthritis Medications Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Prescription Arthritis Medications Sales Market Share by Application (2015-2020)
Table 58. Latin America Prescription Arthritis Medications Sales by Country (2015-2020) (K Units)
Table 59. Latin America Prescription Arthritis Medications Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Prescription Arthritis Medications Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Prescription Arthritis Medications Revenue Market Share by Country (2015-2020)
Table 62. Latin America Prescription Arthritis Medications Sales by Type (2015-2020) (K Units)
Table 63. Latin America Prescription Arthritis Medications Sales Market Share by Type (2015-2020)
Table 64. Latin America Prescription Arthritis Medications Sales by Application (2015-2020) (K Units)
Table 65. Latin America Prescription Arthritis Medications Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Prescription Arthritis Medications Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Prescription Arthritis Medications Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Prescription Arthritis Medications Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Prescription Arthritis Medications Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Prescription Arthritis Medications Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Prescription Arthritis Medications Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Prescription Arthritis Medications Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Prescription Arthritis Medications Sales Market Share by Application (2015-2020)
Table 74. Abbott Corporation Information
Table 75. Abbott Description and Major Businesses
Table 76. Abbott Prescription Arthritis Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Abbott Product
Table 78. Abbott Recent Development
Table 79. Amgen Corporation Information
Table 80. Amgen Description and Major Businesses
Table 81. Amgen Prescription Arthritis Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Amgen Product
Table 83. Amgen Recent Development
Table 84. Boehringer Ingelheim Corporation Information
Table 85. Boehringer Ingelheim Description and Major Businesses
Table 86. Boehringer Ingelheim Prescription Arthritis Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Boehringer Ingelheim Product
Table 88. Boehringer Ingelheim Recent Development
Table 89. Horizon Pharma Corporation Information
Table 90. Horizon Pharma Description and Major Businesses
Table 91. Horizon Pharma Prescription Arthritis Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Horizon Pharma Product
Table 93. Horizon Pharma Recent Development
Table 94. Novartis Corporation Information
Table 95. Novartis Description and Major Businesses
Table 96. Novartis Prescription Arthritis Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Novartis Product
Table 98. Novartis Recent Development
Table 99. Pfizer Corporation Information
Table 100. Pfizer Description and Major Businesses
Table 101. Pfizer Prescription Arthritis Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Pfizer Product
Table 103. Pfizer Recent Development
Table 104. Regeneron Corporation Information
Table 105. Regeneron Description and Major Businesses
Table 106. Regeneron Prescription Arthritis Medications Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Regeneron Product
Table 108. Regeneron Recent Development
Table 109. Global Prescription Arthritis Medications Sales Forecast by Regions (2021-2026) (K Units)
Table 110. Global Prescription Arthritis Medications Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Prescription Arthritis Medications Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Prescription Arthritis Medications Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Prescription Arthritis Medications Sales Forecast by Country (2021-2026) (K Units)
Table 114. North America: Prescription Arthritis Medications Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Prescription Arthritis Medications Sales Forecast by Country (2021-2026) (K Units)
Table 116. Europe: Prescription Arthritis Medications Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Prescription Arthritis Medications Sales Forecast by Region (2021-2026) (K Units)
Table 118. Asia Pacific: Prescription Arthritis Medications Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Prescription Arthritis Medications Sales Forecast by Country (2021-2026) (K Units)
Table 120. Latin America: Prescription Arthritis Medications Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Prescription Arthritis Medications Sales Forecast by Country (2021-2026) (K Units)
Table 122. Middle East and Africa: Prescription Arthritis Medications Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Prescription Arthritis Medications Players
Table 127. Prescription Arthritis Medications Customers List
Table 128. Prescription Arthritis Medications Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Prescription Arthritis Medications Product Picture
Figure 2. Global Prescription Arthritis Medications Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Topical Product Picture
Figure 5. Global Prescription Arthritis Medications Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies
Figure 7. Online Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Prescription Arthritis Medications Report Years Considered
Figure 10. Global Prescription Arthritis Medications Market Size 2015-2026 (US$ Million)
Figure 11. Global Prescription Arthritis Medications Sales 2015-2026 (K Units)
Figure 12. Global Prescription Arthritis Medications Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Prescription Arthritis Medications Sales Market Share by Region (2015-2020)
Figure 14. Global Prescription Arthritis Medications Sales Market Share by Region in 2019
Figure 15. Global Prescription Arthritis Medications Revenue Market Share by Region (2015-2020)
Figure 16. Global Prescription Arthritis Medications Revenue Market Share by Region in 2019
Figure 17. Global Prescription Arthritis Medications Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Prescription Arthritis Medications Revenue in 2019
Figure 19. Prescription Arthritis Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Prescription Arthritis Medications Sales Market Share by Type (2015-2020)
Figure 21. Global Prescription Arthritis Medications Sales Market Share by Type in 2019
Figure 22. Global Prescription Arthritis Medications Revenue Market Share by Type (2015-2020)
Figure 23. Global Prescription Arthritis Medications Revenue Market Share by Type in 2019
Figure 24. Global Prescription Arthritis Medications Market Share by Price Range (2015-2020)
Figure 25. Global Prescription Arthritis Medications Sales Market Share by Application (2015-2020)
Figure 26. Global Prescription Arthritis Medications Sales Market Share by Application in 2019
Figure 27. Global Prescription Arthritis Medications Revenue Market Share by Application (2015-2020)
Figure 28. Global Prescription Arthritis Medications Revenue Market Share by Application in 2019
Figure 29. North America Prescription Arthritis Medications Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Prescription Arthritis Medications Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Prescription Arthritis Medications Sales Market Share by Country in 2019
Figure 32. North America Prescription Arthritis Medications Revenue Market Share by Country in 2019
Figure 33. U.S. Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Prescription Arthritis Medications Market Share by Type in 2019
Figure 38. North America Prescription Arthritis Medications Market Share by Application in 2019
Figure 39. Europe Prescription Arthritis Medications Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Prescription Arthritis Medications Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Prescription Arthritis Medications Sales Market Share by Country in 2019
Figure 42. Europe Prescription Arthritis Medications Revenue Market Share by Country in 2019
Figure 43. Germany Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Prescription Arthritis Medications Market Share by Type in 2019
Figure 54. Europe Prescription Arthritis Medications Market Share by Application in 2019
Figure 55. Asia Pacific Prescription Arthritis Medications Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Prescription Arthritis Medications Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Prescription Arthritis Medications Sales Market Share by Region in 2019
Figure 58. Asia Pacific Prescription Arthritis Medications Revenue Market Share by Region in 2019
Figure 59. China Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Prescription Arthritis Medications Market Share by Type in 2019
Figure 82. Asia Pacific Prescription Arthritis Medications Market Share by Application in 2019
Figure 83. Latin America Prescription Arthritis Medications Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Prescription Arthritis Medications Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Prescription Arthritis Medications Sales Market Share by Country in 2019
Figure 86. Latin America Prescription Arthritis Medications Revenue Market Share by Country in 2019
Figure 87. Mexico Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Prescription Arthritis Medications Market Share by Type in 2019
Figure 94. Latin America Prescription Arthritis Medications Market Share by Application in 2019
Figure 95. Middle East and Africa Prescription Arthritis Medications Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Prescription Arthritis Medications Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Prescription Arthritis Medications Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Prescription Arthritis Medications Revenue Market Share by Country in 2019
Figure 99. Turkey Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Prescription Arthritis Medications Market Share by Type in 2019
Figure 106. Middle East and Africa Prescription Arthritis Medications Market Share by Application in 2019
Figure 107. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Horizon Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Regeneron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. North America Prescription Arthritis Medications Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. North America Prescription Arthritis Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Prescription Arthritis Medications Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Europe Prescription Arthritis Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Prescription Arthritis Medications Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Asia Pacific Prescription Arthritis Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Prescription Arthritis Medications Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Latin America Prescription Arthritis Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Prescription Arthritis Medications Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Middle East and Africa Prescription Arthritis Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
Figure 1. Prescription Arthritis Medications Product Picture
Figure 2. Global Prescription Arthritis Medications Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Topical Product Picture
Figure 5. Global Prescription Arthritis Medications Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies
Figure 7. Online Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Prescription Arthritis Medications Report Years Considered
Figure 10. Global Prescription Arthritis Medications Market Size 2015-2026 (US$ Million)
Figure 11. Global Prescription Arthritis Medications Sales 2015-2026 (K Units)
Figure 12. Global Prescription Arthritis Medications Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Prescription Arthritis Medications Sales Market Share by Region (2015-2020)
Figure 14. Global Prescription Arthritis Medications Sales Market Share by Region in 2019
Figure 15. Global Prescription Arthritis Medications Revenue Market Share by Region (2015-2020)
Figure 16. Global Prescription Arthritis Medications Revenue Market Share by Region in 2019
Figure 17. Global Prescription Arthritis Medications Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Prescription Arthritis Medications Revenue in 2019
Figure 19. Prescription Arthritis Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Prescription Arthritis Medications Sales Market Share by Type (2015-2020)
Figure 21. Global Prescription Arthritis Medications Sales Market Share by Type in 2019
Figure 22. Global Prescription Arthritis Medications Revenue Market Share by Type (2015-2020)
Figure 23. Global Prescription Arthritis Medications Revenue Market Share by Type in 2019
Figure 24. Global Prescription Arthritis Medications Market Share by Price Range (2015-2020)
Figure 25. Global Prescription Arthritis Medications Sales Market Share by Application (2015-2020)
Figure 26. Global Prescription Arthritis Medications Sales Market Share by Application in 2019
Figure 27. Global Prescription Arthritis Medications Revenue Market Share by Application (2015-2020)
Figure 28. Global Prescription Arthritis Medications Revenue Market Share by Application in 2019
Figure 29. North America Prescription Arthritis Medications Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Prescription Arthritis Medications Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Prescription Arthritis Medications Sales Market Share by Country in 2019
Figure 32. North America Prescription Arthritis Medications Revenue Market Share by Country in 2019
Figure 33. U.S. Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Prescription Arthritis Medications Market Share by Type in 2019
Figure 38. North America Prescription Arthritis Medications Market Share by Application in 2019
Figure 39. Europe Prescription Arthritis Medications Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Prescription Arthritis Medications Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Prescription Arthritis Medications Sales Market Share by Country in 2019
Figure 42. Europe Prescription Arthritis Medications Revenue Market Share by Country in 2019
Figure 43. Germany Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Prescription Arthritis Medications Market Share by Type in 2019
Figure 54. Europe Prescription Arthritis Medications Market Share by Application in 2019
Figure 55. Asia Pacific Prescription Arthritis Medications Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Prescription Arthritis Medications Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Prescription Arthritis Medications Sales Market Share by Region in 2019
Figure 58. Asia Pacific Prescription Arthritis Medications Revenue Market Share by Region in 2019
Figure 59. China Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Prescription Arthritis Medications Market Share by Type in 2019
Figure 82. Asia Pacific Prescription Arthritis Medications Market Share by Application in 2019
Figure 83. Latin America Prescription Arthritis Medications Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Prescription Arthritis Medications Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Prescription Arthritis Medications Sales Market Share by Country in 2019
Figure 86. Latin America Prescription Arthritis Medications Revenue Market Share by Country in 2019
Figure 87. Mexico Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Prescription Arthritis Medications Market Share by Type in 2019
Figure 94. Latin America Prescription Arthritis Medications Market Share by Application in 2019
Figure 95. Middle East and Africa Prescription Arthritis Medications Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Prescription Arthritis Medications Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Prescription Arthritis Medications Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Prescription Arthritis Medications Revenue Market Share by Country in 2019
Figure 99. Turkey Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Prescription Arthritis Medications Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Prescription Arthritis Medications Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Prescription Arthritis Medications Market Share by Type in 2019
Figure 106. Middle East and Africa Prescription Arthritis Medications Market Share by Application in 2019
Figure 107. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Horizon Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Regeneron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. North America Prescription Arthritis Medications Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. North America Prescription Arthritis Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Prescription Arthritis Medications Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Europe Prescription Arthritis Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Prescription Arthritis Medications Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Asia Pacific Prescription Arthritis Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Prescription Arthritis Medications Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Latin America Prescription Arthritis Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Prescription Arthritis Medications Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Middle East and Africa Prescription Arthritis Medications Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
